08/12/22 5:56 PMNasdaq : ADOC, ADOC.U, ADOC-U acquisitionlow floatEdoc Acquisition Corp. Announces Termination of Merger Agreement with Calidi Biotherapeutics, Inc.Edoc Acquisition Corp. (Nasdaq: ADOC, ADOCR, ADOCW, “EDOC” or the “Company”), a special purpose acquisition company, announced today the termination of its previously announced agreement and plan of merger (the “Merger Agreement”) with CalidiRHEA-AIneutral
08/12/22 10:02 AMNasdaq : ADOC, ADOC.U, ADOC-U acquisitionlow floatEdoc Acquisition Corp. Announce Postponement of Special Meeting of Shareholders to Extend the Deadline to Consummate an Initial Business Combination Edoc Acquisition Corp. (Nasdaq: ADOC, ADOCR, ADOCW, “EDOC” or the “Company”), today announced the postponement of Edoc’s extraordinaryRHEA-AIneutral
08/04/22 5:17 PMNasdaq : ADOC, ADOC.U, ADOC-U acquisitionlow floatEdoc Acquisition Corp. Reminds Shareholders to Vote and Announces Additional Contribution for Extension AmendmentEdoc Acquisition Corp. (Nasdaq: ADOC, ADOCR, ADOCW, “EDOC” or the “Company”) encourages its shareholders to vote in favor of the proposal to amend its charter (the “Extension Amendment”) to extend the date by which the Company has to complete a businessRHEA-AIneutral
02/07/22 9:06 AMNasdaq : ADOC, ADOC.U, ADOC-U acquisitionlow floatEdoc Acquisition Corp. Reminds Shareholders to Vote in Favor of Extension AmendmentEdoc Acquisition Corp. (Nasdaq: ADOC, ADOCR, and ADOCW) (“Edoc” or the “Company”) encourages its shareholders to vote in favor of the proposal to amend its charter (the “Extension Amendment”) to extend the date by which the Company has to complete aRHEA-AIneutral
02/02/22 12:40 PMNasdaq : ADOC, ADOC.U, ADOC-U acquisitionlow floatCalidi Biotherapeutics and Edoc Acquisition Corp. Agree to Merge and Create a Publicly Listed, Clinical-Stage Biotechnology Company Utilizing Stem Cell-Based Platforms to Revolutionize Oncolytic Virotherapies-Total gross proceeds from transaction expected to be approximately $117 million prior to redemptions, combining $25 million PIPE and up to $92 million held in Edoc trust account- -Anticipated cash resources will fund Calidi’s NeuroNova and SuperNova development programs through multiple clinicalRHEA-AIneutral
11/15/21 4:15 PMNasdaq : ADOC, ADOC.U, ADOC-U acquisitionlow floatEDOC Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business CombinationEDOC Acquisition Corp. (NASDAQ: ADOC) (the “Company”), announced today that an aggregate of $900,000 (the “Extension Payment”) has been deposited into the Company’s trust account for its public shareholders, representing $0.10 per public share, whichRHEA-AIneutral
11/09/21 4:15 PMNasdaq : ADOC, ADOC.U, ADOC-U acquisitionlow floatEDOC Acquisition Corp. Announces Sponsor Approval of Extension of Deadline to Complete Business CombinationEDOC Acquisition Corp. (NASDAQ: ADOC) (the “Company”), a publicly traded special purpose acquisition company, announced today that its sponsor, American Physicians LLC (the “Sponsor”), has requested that the Company extend the date by which theRHEA-AIneutral
